المؤلفون: Solenn Brosseau, Valérie Gounant, Sandra Assoun, Gérard Zalcman, Christelle Steinmetz

المصدر: Future Oncology. 13:2515-2535

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, medicine.medical_treatment, Immune checkpoint inhibitors, Drug Evaluation, Preclinical, Angiogenesis Inhibitors, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Product Surveillance, Postmarketing, Animals, Humans, Medicine, Molecular Targeted Therapy, Clinical efficacy, Lung cancer, Randomized Controlled Trials as Topic, Clinical Trials as Topic, Chemotherapy, business.industry, General Medicine, medicine.disease, respiratory tract diseases, Angiogenesis inhibitor, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Retreatment, Monoclonal, Disease Progression, Metastatic lung cancer, business, Biomarkers, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8ef7352ff62fbb9c08d6407cfcb9c26
https://doi.org/10.2217/fon-2017-0302

المؤلفون: Valérie Gounant, Solenn Brosseau, C. Naltet, Christelle Steinmetz, Sandra Assoun, Gérard Zalcman

المصدر: Future oncology (London, England). 13(28)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Mesothelioma, Cancer Research, medicine.medical_specialty, Lung Neoplasms, genetic structures, Bevacizumab, Pleural Neoplasms, Drug Evaluation, Preclinical, Angiogenesis Inhibitors, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Animals, Humans, Molecular Targeted Therapy, Randomized Controlled Trials as Topic, Cisplatin, Clinical Trials as Topic, Pleural mesothelioma, business.industry, Mesothelioma, Malignant, Cancer, General Medicine, medicine.disease, Angiogenesis inhibitor, 030104 developmental biology, Pemetrexed, Treatment Outcome, 030220 oncology & carcinogenesis, Monoclonal, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e996ed0213cf037ca05504a86b255d
https://pubmed.ncbi.nlm.nih.gov/29086616